Alaa Halawa's Insider Trades & SAST Disclosures

Alaa Halawa's most recent trade in Neumora Therapeutics Inc. was a trade of 46,455 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Feb. 13, 2025.

Stock Client Name Client Category Action Reported to Exchange Quantity Post Transaction Holding Traded % Avg. Price Value Security Type
Neumora Therapeutics Inc.
Alaa Halawa Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2025 46,455 46,455 - - Stock Option (Right to Buy)
Neumora Therapeutics Inc.
Alaa Halawa Director Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Feb 2025 46,455 0 - - Stock Option (Right to Buy)
Neumora Therapeutics Inc.
Alaa Halawa Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Feb 2025 28,571 28,571 - - Stock Option (Right to Buy)
Neumora Therapeutics Inc.
Alaa Halawa Director Sale or transfer of securities back to the company at price $ 0.00 per share. 13 Feb 2025 28,571 0 - - Stock Option (Right to Buy)
Neumora Therapeutics Inc.
Alaa Halawa Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 28,571 28,571 - - Stock Option (Right to Buy)
Neumora Therapeutics Inc.
Alaa Halawa Director Grant, award, or other acquisition of securities at price $ 0.00 per share. 13 Jun 2024 20,100 20,100 - 0 Common Stock
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc  
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges
View All The Insider Trades